Matches in Harvard for { <http://id.lib.harvard.edu/aleph/007463027/catalog> ?p ?o. }
Showing items 1 to 29 of
29
with 100 items per page.
- catalog contributor b10304207.
- catalog created "c1997.".
- catalog date "1997".
- catalog date "c1997.".
- catalog dateCopyrighted "c1997.".
- catalog description "Includes bibliographical references and index.".
- catalog description "pt. 1. In vitro methods -- High-volume screening -- The NCI in vitro anticancer drug discovery screen: concept, implementation, and operation, 1985-1995 -- Human tumor screening -- pt. 2. In vivo methods -- Murine L1210 and P388 leukemias -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery -- Human tumor xenograft models in NCI drug development -- Fertile seed and rich soil: the development of clinically relevant models of human cancer by surgical orthotopic implantation of intact tissue -- Preclinical models for high-dose therapy -- Models for minimal residual tumor -- Spontaneously occurring tumors in companion animals as models for drug development -- pt. 3. Clinical testing -- Working with the National Cancer Institute -- Phase I trial design and methodology -- Phase II clinical trials in oncology -- Drug development in Europe -- The phase III cancer clinical trial -- FDA role in cancer drug development and requirements for approval.".
- catalog extent "xii, 311 p. :".
- catalog hasFormat "Anticancer drug development guide.".
- catalog identifier "0896034607 (alk. paper)".
- catalog isFormatOf "Anticancer drug development guide.".
- catalog isPartOf "Cancer drug discovery and development".
- catalog issued "1997".
- catalog issued "c1997.".
- catalog language "eng".
- catalog publisher "Totowa, N.J. : Humana Press,".
- catalog relation "Anticancer drug development guide.".
- catalog subject "1997 G-346".
- catalog subject "616.99/4061 21".
- catalog subject "Antineoplastic Agents standards.".
- catalog subject "Antineoplastic agents Development.".
- catalog subject "Antineoplastic agents Testing.".
- catalog subject "Drug Approval.".
- catalog subject "Drug Evaluation, Preclinical".
- catalog subject "QV 269 A62953 1997".
- catalog subject "RC271.C5 A6722 1997".
- catalog tableOfContents "pt. 1. In vitro methods -- High-volume screening -- The NCI in vitro anticancer drug discovery screen: concept, implementation, and operation, 1985-1995 -- Human tumor screening -- pt. 2. In vivo methods -- Murine L1210 and P388 leukemias -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery -- Human tumor xenograft models in NCI drug development -- Fertile seed and rich soil: the development of clinically relevant models of human cancer by surgical orthotopic implantation of intact tissue -- Preclinical models for high-dose therapy -- Models for minimal residual tumor -- Spontaneously occurring tumors in companion animals as models for drug development -- pt. 3. Clinical testing -- Working with the National Cancer Institute -- Phase I trial design and methodology -- Phase II clinical trials in oncology -- Drug development in Europe -- The phase III cancer clinical trial -- FDA role in cancer drug development and requirements for approval.".
- catalog title "Anticancer drug development guide : preclinical screening, clinical trials, and approval / edited by Beverly A. Teicher.".
- catalog type "text".